MedImpact is not requiring patients currently taking Humira to switch, and all three products are on a preferred tier. MedImpact Healthcare Systems is providing access to two Humira biosimilars: ...
Beginning in 2025, Express Scripts will favor biosimilars of Humira, including its own private-label version. Beginning in 2025, Express Scripts will remove Humira (adalimumab) from its commercial ...